GRI Bio (GRI) Share-based Compensation (2020 - 2026)
GRI Bio (GRI) posted quarterly Share-based Compensation of $31000.0 for Q1 2026, down 85.91% year-over-year from $220000.0 in Q1 2025, and down 53.73% quarter-over-quarter from $67000.0 in Q4 2025.
GRI Bio (GRI) Share-based Compensation (2020 - 2026) Analysis & Trends
GRI Bio's Share-based Compensation history runs 7 years deep, the most recent figure standing at $31000.0 for Q1 2026.
- In Q1 2026, Share-based Compensation fell 85.91% year-over-year to $31000.0; the TTM figure through Mar 2026 stood at $604000.0 (up 82.48% YoY), while the FY2025 annual figure was $793000.0, up 435.81% from the prior year.
- Share-based Compensation for Q1 2026 stood at $31000.0, down from $67000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $465000.0 in Q3 2025, with the low at -$181000.0 in Q2 2022.
- The 5-year median for Share-based Compensation is $37000.0 (2024), against an average of $86562.5.
- The sharpest annual moves came in 2022 and 2025: Share-based Compensation slumped 231.16% in 2022, then surged 1156.76% in 2025.
- GRI Bio's Share-based Compensation stood at $25000.0 in 2022, then jumped by 44.0% to $36000.0 in 2023, then increased by 2.78% to $37000.0 in 2024, then soared by 81.08% to $67000.0 in 2025, then tumbled by 53.73% to $31000.0 in 2026.
- Business Quant data shows GRI's Share-based Compensation at $31000.0 in Q1 2026, $67000.0 in Q4 2025, and $465000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 86.63 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 28.05 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 41.25 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | GRI Bio | 3.01 Mn | 3.01 Mn | - | 33,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31,000.00 |
| Mar 31, 2026 | 31,000.00 |
| Dec 31, 2025 | 67,000.00 |
| Dec 31, 2025 | 67,000.00 |
| Sep 30, 2025 | 465,000.00 |
| Sep 30, 2025 | 465,000.00 |
| Jun 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 41,000.00 |
| Mar 31, 2025 | 220,000.00 |
| Mar 31, 2025 | 220,000.00 |
| Dec 31, 2024 | 37,000.00 |
| Dec 31, 2024 | 37,000.00 |
| Sep 30, 2024 | 37,000.00 |
| Sep 30, 2024 | 37,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Dec 31, 2023 | 36,000.00 |
| Dec 31, 2023 | 36,000.00 |